GlaxoSmithKline Plc has highlighted projects in its late-stage pipeline in disclosing its financial results for the 2012 first quarter. These results showed an increase in revenue and operating profit of 2% as measured in constant exchange rates. ---Subscribe to MedNous to access this article--- Company News
